Sildenafil/Dapoxetine
西地那非/达泊西汀
Report date: 2022/01/14 13:23:58
Base Information
Drug NameSildenafil/Dapoxetine
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Sildenafil CitrateDapoxetine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEmcure Pharma
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A